Biolife Sciences (Biolife Sciences) Change In Inventory : $0.00 Mil (TTM As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Change In Inventory?

Biolife Sciences's change in inventory for the quarter that ended in May. 2008 was $0.00 Mil. It means Biolife Sciences's inventory stayed the same from Feb. 2008 to May. 2008 .

Biolife Sciences's change in inventory for the fiscal year that ended in Nov. 2007 was $0.00 Mil. It means Biolife Sciences's inventory stayed the same from Nov. 2006 to Nov. 2007 .

Biolife Sciences's Total Inventories for the quarter that ended in May. 2008 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biolife Sciences's Days Inventory for the quarter that ended in May. 2008 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biolife Sciences's Inventory-to-Revenue for the quarter that ended in May. 2008 was 0.00.

Biolife Sciences Change In Inventory Historical Data

The historical data trend for Biolife Sciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Change In Inventory Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Change In Inventory

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Change In Inventory	Get a 7-Day Free Trial										-	-	-	-	-

Biolife Sciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Biolife Sciences (OTCPK:BLFE) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biolife Sciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	1.442	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biolife Sciences's Inventory Turnover for the quarter that ended in May. 2008 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.442	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biolife Sciences's Inventory to Revenue for the quarter that ended in May. 2008 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	1.798
	=	0.00

Biolife Sciences Change In Inventory Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020